The maker of Subxone is the latest pharmaceutical company to settle rather than face trial for alleged. The company will pay $1.4 billion to the U.S government to settle — the largest opioid-related settlement to date.
From The Hill:
Reckitt Benckiser Group, the manufacturer of Suboxone, a treatment for opioid addiction, agreed to the settlement to end criminal and civil probes into the business, but it denied any wrongdoing.
The Department of Justice (DOJ) said the British company illegally marketed Suboxone as less addictive and safer than other drugs with the same active ingredient that is intended to treat opioid withdrawal.
As previously reported on Conduit Street, Purdue Pharma LLC, the maker of OxyContin, reached a settlement with the Attorney General for Oklahoma earlier this year over a lawsuit in which the state alleged that Purdue, as well as other opioid manufacturers, contributed to the deadly opioid crisis through deceptive marketing practices.
For more information:
Purdue Pharma Settles Opioid Lawsuit with Oklahoma Attorney General (Conduit Street)
Learn about cutting edge state and local programs focused on addressing opioid issues at the MACo Summer Conference session, “New Tools for Tracking and Treating Opioid and Mental Health Crises.” The session is scheduled for Friday, August 16, 2019, from 2:15 pm – 3:15 pm.
The MACo Summer Conference will be held August 14-17, 2019 at the Roland Powell Convention Center in Ocean City, Maryland. This year’s conference theme is “Winds of Change.”
Learn more about MACo’s Summer Conference: